Ibuprofen (Ibuprofen)

BETTER LIVING BRANDS LLC. · tablet · NDC 21130-396

Listed in the FDA National Drug Code directory

Ibuprofen is an over-the-counter medicine made available by BETTER LIVING BRANDS LLC., on the U.S. market since July 2019. It is marketed under an FDA approval (ANDA ANDA079174), so the FDA has reviewed its safety, effectiveness and manufacturing. A listing proves the product exists; it does not prove that a particular pack is genuine, so compare yours with the official description below.

What the genuine product looks like

From the official FDA label (version of Dec 18, 2025). Compare the colour, shape, imprint and packaging with what you have. Any difference is a reason to ask a pharmacist before taking it.

Product data on the label: Ibuprofen Ibuprofen STARCH, CORN STEARIC ACID POLYETHYLENE GLYCOL 4000 TITANIUM DIOXIDE POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A POTATO IBUPROFEN IBUPROFEN TALC SILICON DIOXIDE FERRIC OXIDE RED Reddish Brown color Tablets G;2

Text on the package panel: Principal Display Panel 50ct

What it is for

Purpose Pain reliever/fever reducer

Key warnings

Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include: ■ hives ■ facial swelling ■ asthma (wheezing) ■ shock ■ skin reddening ■ rash ■ blisters If an allergic reaction occurs, stop use and seek medical help right away.

Excerpts from the FDA label. Always read the leaflet in your pack and ask a pharmacist or doctor about your own situation.

Advertisement

Recalls of this product

No FDA recalls are recorded for NDC 21130-396. Recalls are listed in FDA enforcement reports from 2004 onward.

Other recent recalls of ibuprofen

Same active ingredient, other companies or packs. Check the company and lot number on your pack.

Class II · Mar 25, 2026 · STRIDES PHARMA INC

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Class II · Apr 16, 2025 · Glenmark Pharmaceuticals Inc., USA

CGMP Deviations

Class III · Nov 27, 2024 · Dr. Reddy's Laboratories, Inc.

Failed Tablet/Capsule Specifications

Class II · Sep 4, 2024 · Dr. Reddy's Laboratories, Inc.

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Class II · Sep 4, 2024 · Dr. Reddy's Laboratories, Inc.

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Class II · Sep 4, 2024 · Dr. Reddy's Laboratories, Inc.

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Class II · Jun 15, 2022 · Mckesson Medical-Surgical Inc. Corporate Office

cGMP deviations: Temperature abuse

Class II · Jun 2, 2021 · Cardinal Health Inc.

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Most reported side effects for ibuprofenReports to the FDA Adverse Event Reporting System (FAERS), all products with this ingredient
Drug ineffective27,695 reports
Pain19,683 reports
Fatigue19,020 reports
Nausea18,574 reports
Headache16,765 reports
Arthralgia13,653 reports
Dyspnoea13,294 reports
Vomiting13,218 reports
Diarrhoea12,905 reports
Dizziness11,570 reports
Show as table
ItemValue (reports)
Drug ineffective27,695
Pain19,683
Fatigue19,020
Nausea18,574
Headache16,765
Arthralgia13,653
Dyspnoea13,294
Vomiting13,218
Diarrhoea12,905
Dizziness11,570

These counts are reports, not proof that the medicine caused the problem. Popular medicines get more reports simply because more people take them. They are useful for spotting what to watch for, not for comparing medicines.

Official listing

Brand
Ibuprofen
Generic name
Ibuprofen
Company
BETTER LIVING BRANDS LLC.
Form
tablet
Route
oral
Type
HUMAN OTC DRUG
Category
ANDA
Listing valid to
Dec 31, 2026
Product NDC
21130-396

Active ingredients

Ibuprofen
200 mg/1

Packages (2)

The last part of the NDC identifies the pack size. Your box should show one of these.

21130-396-05 50 tablet in 1 bottle (21130-396-05)
21130-396-25 250 tablet in 1 bottle (21130-396-25)

Think your pack is fake?

Stop taking it, keep the pack and receipt, and show it to a pharmacist. In the U.S., report it to FDA MedWatch; elsewhere, to your national medicines regulator. How to spot a fake medicine.

Source: openFDA (U.S. Food and Drug Administration) drug directory, labels, enforcement reports and FAERS, retrieved Nov 8, 2026. The FDA notes this data should not be relied on alone for medical decisions. Not medical advice.